C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/04/2004	WO2004094616A2 Silencing transcription by methylation
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094611A2 Reprogramming nuclear function with somatic cell cytoplasm
11/04/2004	WO2004094610A2 Wnt as a factor for cardiac myogenesis
11/04/2004	WO2004094606A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2
11/04/2004	WO2004094603A2 Transgenic mouse with simplified dh locus
11/04/2004	WO2004094598A2 Methods of use for novel human polypeptides encoded by polynucleotides
11/04/2004	WO2004094593A2 Expanding the eukaryotic genetic code
11/04/2004	WO2004094592A2 Polymer-conjugated glycosylated neublastin
11/04/2004	WO2004094590A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004	WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004	WO2004094472A2 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
11/04/2004	WO2004094466A2 Recombinant influenza viruses holding a mutation in a transmembrane protein gene
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094447A1 Thionucleoside s-nitrosyl derivative
11/04/2004	WO2004094445A1 A more stable analog of iso-propylthiogalactoside for induction of protein expression
11/04/2004	WO2004093919A2 Target for cancer therapy and drug discovery
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093907A2 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents
11/04/2004	WO2004093906A1 Immunogenic composition and methods
11/04/2004	WO2004093905A1 Human cytomegalovirus antigens expressed in mva and methods of use
11/04/2004	WO2004093820A2 Methods and compositions for solid tumor treatment
11/04/2004	WO2004093810A2 Methods and compositions for treating disorders
11/04/2004	WO2004093808A2 Novel tumor-associated antigens
11/04/2004	WO2004093790A2 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004	WO2004093788A2 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004	WO2004093785A2 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004	WO2004093783A2 Modulation of apolipoprotein c-iii expression
11/04/2004	WO2004093778A2 Oligonucleotides that block toll-like receptors
11/04/2004	WO2004093645A2 Tn5 transposase mutants and the use thereof
11/04/2004	WO2004093532A2 Generation of plants with altered oil content
11/04/2004	WO2004093531A2 Generation of plants with altered oil content
11/04/2004	WO2004093530A2 Generation of plants with altered oil content
11/04/2004	WO2004093529A2 Generation of plants with altered oil content
11/04/2004	WO2004093528A2 Generation of plants with altered oil content
11/04/2004	WO2004083373A3 Antibody against the g glycoprotein of respiraotry syncytial virus
11/04/2004	WO2004083362A3 Modification of subtilases using protein modelling based on the jp170 three-dimensional structure
11/04/2004	WO2004083361A3 FVII OR FVIIa VARIANTS
11/04/2004	WO2004083245A3 Agent comprise an albumin-like first polypeptide bound to a second polypeptide
11/04/2004	WO2004081167A3 Expression vectors comprising the mcmv ie2 promoter
11/04/2004	WO2004081150A3 Methyl esters of hydroxyl-containing fatty acids as biofuels
11/04/2004	WO2004079325A3 Ph dependent signaling dna enzymes
11/04/2004	WO2004065574A3 Bacteria for high efficiency cloning
11/04/2004	WO2004065555A3 Regulator/promoter for tunable gene expression and metabolite sensing
11/04/2004	WO2004064744A3 Methods for site-directed mutagenesis and targeted randomization
11/04/2004	WO2004061080A3 Stress-related polypeptides and uses therefor
11/04/2004	WO2004061077A3 Increasing gamete production with a gene switch
11/04/2004	WO2004057001A3 Method for the production of polyunsaturated fatty acids
11/04/2004	WO2004053075A3 Compositions, splice variants and methods relating to breast specific genes and proteins
11/04/2004	WO2004052925A3 Actinobacillus pleuropneumoniae virulence genes
11/04/2004	WO2004050883A3 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
11/04/2004	WO2004050847A3 Modified antibodies stably produced in milk and methods of producing same
11/04/2004	WO2004048575A3 Streptococcus pneumoniae surface polypeptides
11/04/2004	WO2004043395A3 Methods and compositions for treating neurological disorders
11/04/2004	WO2004043387A3 Compositions and methods for cancer diagnosis and therapy
11/04/2004	WO2004039412A3 Compositions for cancer treatment
11/04/2004	WO2004035798A3 Identification of e2f target genes and uses thereof
11/04/2004	WO2004034029A3 Screening systems and methods for identifying modulators of xenobiotic metabolism
11/04/2004	WO2004027043A3 Method for production of a multimeric protein by cell fusion
11/04/2004	WO2004027024A3 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis
11/04/2004	WO2004024227A3 Systems of sperm cell preservation and processing
11/04/2004	WO2004024069A9 Novel compositions and methods for the treatment of immune-related diseases
11/04/2004	WO2004022003A3 Materials and methods for treatment of allergic diseases
11/04/2004	WO2004019676A3 Animal model for perimenopause and menopause and methods of inducing ovarian failure
11/04/2004	WO2004009618A3 Recombinant production of mixtures of antibodies
11/04/2004	WO2004005461A3 Antisense modulation of insulin-like growth factor 2 expression
11/04/2004	WO2004002223A3 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
11/04/2004	WO2003104422A3 Mahoganoid polypeptides, and related compositions and methods
11/04/2004	WO2003102200A3 Fermentation process using specific oxygen uptake rates as a process control
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003093482A3 Method for producing multiple unsaturated fatty acids in plants
11/04/2004	WO2003092612A3 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/04/2004	WO2003091403A3 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003087115A3 Oligomeric compounds having modified phosphate groups
11/04/2004	WO2003082195A3 Protamine-adenoviral vector complexes and methods of use
11/04/2004	WO2003076593A3 Genomic screen for epigenetically silenced genes associated with cancer
11/04/2004	WO2003069984A9 Transgenic production in saliva
11/04/2004	WO2003063784A3 MOLECULES THAT MODULATE GαQ ACTIVITY AND METHODS OF TREATING URINARY INCONTINENCE
11/04/2004	WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004	WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2003004696A3 A distributed system for epigenetic based prediction of complex phenotypes
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	WO2002072030A8 High affinity integrin polypeptides and uses thereof
11/04/2004	US20040221338 Ribosomal RNA regulatory sequences for use as tools in controlling heterologous gene expression; chloroplast transcription modulating element; tissue engineering
11/04/2004	US20040221337 Using short RNA sequences to control endogenous gene expression through post-transcriptional gene silencing; tissue engineering
11/04/2004	US20040221336 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/04/2004	US20040221335 Transforming plant with expression vector comprising nucleotide sequences coding fatty acid desaturase; for use in enhancing concentration of fatty acid in crop plants; tissue engineering and heterologous gene expression; enhancing nutrients of animal feeds
11/04/2004	US20040221334 Immunoglobulin for use in detection of modified insecticidal protein; immunodiagnostics and heterologous gene expression; tissue engineering and biological pest control
11/04/2004	US20040221333 Transgenic plants comprising nucleotide sequences coding insectcidal proteins for use in propagation insect resistant crop plants; tissue engineering and biological pest control
11/04/2004	US20040221332 Plant growth regulating genes, proteins and uses thereof
11/04/2004	US20040221331 Male tissue-preferred regulatory sequences of Ms45 gene and method of using same
11/04/2004	US20040221330 Preparing genetically engineered plant comprising vector with modified upstream regulatory sequences for use as tool in heterologous gene expression in plants; bioreactors; tissue engineering
11/04/2004	US20040221327 Antibodies against autoantigens of primary billary cirrhosis and methods of making and using them
11/04/2004	US20040221326 Transgenic animal model of bone mass modulation
11/04/2004	US20040220536 Apparatus with weeping tip and method of use
11/04/2004	US20040220535 Transferring materials into cells porous silicon
11/04/2004	US20040220396 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same

1 ... 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 ... 4023